Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on April 7, 2025
Gilat Awarded Up to $23 Million Multi-Year Contract to Service Satellite Transportable Terminal Units for US DoD Customers
GlobeNewswire
·
April 7, 2025
PETAH TIKVA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat Defense was awarded a contract to …
Shoals Technologies Group, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
April 7, 2025
PORTLAND, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2025 results before market open on Tuesday, May 6, 2025, to be followed by a …
Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer
GlobeNewswire
·
April 7, 2025
DETROIT, April 07, 2025 (GLOBE NEWSWIRE) -- Atwater Brewing, Detroit’s renowned craft brewery and a craft beer brand of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce the launch of Atwater Light, a low-calorie, low-carb addition …
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
GlobeNewswire
·
April 7, 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia …
ADMA Biologics Statement on Tariffs
GlobeNewswire
·
April 7, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics …
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
GlobeNewswire
·
April 7, 2025
Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody, could have a human half-life as long as 130 days Additional interim in vivo data for a first-in-class Activin E antibody shows …
LG U+ Uses Denodo Platform to Build Modern, Integrated Data Management Infrastructure
GlobeNewswire
·
April 7, 2025
SEOUL, South Korea, April 07, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that it will provide its logical data management solution, the Denodo Platform, to LG U+, the mobile operator division of LG and the second-largest …
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
GlobeNewswire
·
April 7, 2025
-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- -- -19.2% placebo-adjusted BMI reduction achieved in adult patients 18 years …
Update on Extraordinary General Meeting – Extension of Zijin Put Option and Exclusivity Arrangements
GlobeNewswire
·
April 7, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 12 March 2025 in relation to an Extraordinary General Meeting (EGM) to be held on Friday, 11 April 2025. The EGM …
Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
April 7, 2025
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelines Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for …
Holding(s) in Company
GlobeNewswire
·
April 7, 2025
Reykjavík, April 07, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the …
Telix Appoints Paul Schaffer as Chief Technology Officer
GlobeNewswire
·
April 7, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology …
Wesdome Gold Mines to Acquire Angus Gold; Quadruples the Eagle River Land Package
GlobeNewswire
·
April 7, 2025
All amounts are expressed in Canadian dollars unless otherwise indicated TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) and Angus Gold Inc. (TSX-V: GUS, OTC: ANGVF) (“Angus”) are …
Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 7, 2025
HUNTSVILLE, AL, April 07, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …
Jitterbit Earns 20 G2 Spring 2025 Badges for Leadership in Enterprise Automation, Integration and App Development
GlobeNewswire
·
April 7, 2025
ALAMEDA, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced its Harmony platform has been recognized as a leader by G2, the world's largest and most trusted …
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
GlobeNewswire
·
April 7, 2025
Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants across cardiac biomarkers and functional measures All …
ExoraPad Presale Surges Past 70,000 XRP Raised, Set For DEX Launch and Launchpad Prototype Release in Q2 2025
GlobeNewswire
·
April 7, 2025
CORK, Ireland, April 07, 2025 (GLOBE NEWSWIRE) -- The excitement within the XRP community is hitting new highs as the ExoraPad presale explodes, crossing a remarkable milestone of 70,000 XRP raised. XRP enthusiasts and seasoned crypto investors, fresh from …
Trident Deepens Partnership with Democratic Republic of Congo for Digital Identity System
GlobeNewswire
·
April 7, 2025
SINGAPORE, April 07, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (NASDAQ: TDTH) (“Trident” or the “Company”), a Singapore-based leader in digital transformation, technology optimization, and Web 3.0 activation, today announced progress in …
AACSB Report Reveals Key Shifts Shaping Business Education
GlobeNewswire
·
April 7, 2025
The report explores business school financial viability, enrollment trends and learner expectations, and increasingly complex faculty and leadership roles. TAMPA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- AACSB International is proud to release its 2025 …
Himax Technologies, Inc. Schedules First Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025, at 8:00 AM EDT
GlobeNewswire
·
April 7, 2025
TAINAN, Taiwan, April 07, 2025 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that it will hold a …